BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merker M, Eichler S, Herrmann AM, Wiendl H, Kleinschnitz C, Göbel K, Meuth SG. Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis. J Neuroimmunol 2017;313:125-8. [PMID: 28992973 DOI: 10.1016/j.jneuroim.2017.08.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Göbel K, Kleinschnitz C, Meuth SG. [Coagulation factors and multiple sclerosis : Key factors in the pathogenesis?]. Nervenarzt 2018;89:908-12. [PMID: 29404650 DOI: 10.1007/s00115-018-0491-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Schaefer JH, Yalachkov Y, Friedauer L, Kirchmayr K, Miesbach W, Wenger KJ, Foerch C, Schaller-paule MA. Measurement of prothrombin fragment 1+2 in cerebrospinal fluid to identify thrombin generation in inflammatory central nervous system diseases. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103720] [Reference Citation Analysis]
3 Göbel K, Asaridou CM, Merker M, Eichler S, Herrmann AM, Geuß E, Ruck T, Schüngel L, Groeneweg L, Narayanan V, Schneider-Hohendorf T, Gross CC, Wiendl H, Kehrel BE, Kleinschnitz C, Meuth SG. Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release. Proc Natl Acad Sci U S A 2019;116:271-6. [PMID: 30559188 DOI: 10.1073/pnas.1810020116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
4 Ziliotto N, Baroni M, Straudi S, Manfredini F, Mari R, Menegatti E, Voltan R, Secchiero P, Zamboni P, Basaglia N, Marchetti G, Bernardi F. Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis. Front Neurol 2018;9:245. [PMID: 29731736 DOI: 10.3389/fneur.2018.00245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Bierhansl L, Hartung HP, Aktas O, Ruck T, Roden M, Meuth SG. Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Discov 2022. [PMID: 35668103 DOI: 10.1038/s41573-022-00477-5] [Reference Citation Analysis]
6 Göbel K, Meuth SG. Brain fibrinogen deposition plays a key role in MS pathophysiology - No. Mult Scler 2019;25:1436-7. [PMID: 31315524 DOI: 10.1177/1352458518820240] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]